Explores how an essential medicines list could improve access and equity in dermatology, suggesting potential policy implications.
No takes yet. Share an insight, caveat, or question.
Larney et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: